COVID-19: Impact on Telehealth

July 2020 Vol 11, No 7

Categories:

COVID-19

Telehealth continues to play a critical role in providing healthcare services to patients during the COVID-19 pandemic. In a webcast titled COVID-19: Impact on Telehealth, Rick Lee, Executive Chairman, Healthy Platforms and CancerLife, along with a panel of experts discussed the benefits and ongoing challenges associated with the use of telemedicine and the far-reaching impact of this technology beyond the current crisis.

Rick Lee
Chevon Rariy, MD
Brian Leyland-Jones, MD

Bob Gold
Burt Zweigenhaft, PhD, DLitt

Telehealth has emerged as an essential component of healthcare during the COVID-19 crisis. In a wide-ranging discussion, a panel of experts discussed the current benefits and ongoing challenges of this technology, as well as its potential impact on patients and practices in the years to come.

“It’s taken this crisis to push us to a new frontier, but there’s absolutely no going back,” said the  moderator of the discussion, Rick Lee, Executive Chairman, Healthy Platforms and CancerLife, as he referred to the speed with which patients and providers have embraced telemedicine. He provided a summary of the changes that have occurred since the beginning of the pandemic, including decisions by the Centers for Medicare & Medicaid Services (CMS) that have allowed expanded use of telehealth services. These changes have led to a significant increase in the number of telehealth visits that have occurred, contributing to the widespread acceptance of this modality.

Although telemedicine is now widely accepted, there are certain complexities related to administration and practice that must be appropriately managed for continued success.

“Having regulatory experience is imperative, in particular during this time when things are very fast-moving and fast-paced and we’re seeing changes in CMS rules and regulations almost biweekly,” said Chevon Rariy, MD, Director, Telehealth, Cancer Treatment Centers of America. In particular, “medical records maintenance is key” when deploying a telehealth program that is embedded within a larger healthcare system, he noted.

Brian Leyland-Jones, MD, Chief Medical Officer, National Foundation for Cancer Research, pointed out that in the delivery of specialized healthcare in a rural environment, where patients were required to travel up to 500 miles to a clinic, systems were already in place and functioning well. “We have all adjusted so rapidly,” he said.

During the discussion, the experts also considered the ways in which telehealth services can be used to address patient needs beyond the immediate impact of the coronavirus. For example, the use of telehealth services for patients with illnesses other than cancer is a potential area of expansion. It is already being used in some programs to mitigate loneliness among patients whose illness or geography results in social distancing that is not solely pandemic-related. “Loneliness is disease agnostic,” Karen Keown, RN, Co-Founder, Vida Healthcare, said, referring to these patients.

The panelists also explored how telemedicine could potentially affect clinical trials and other multidisciplinary applications. “There is a concern that they cannot get enough patients into clinical trials and it’s hurting research. And then there’s the retention aspect.” Rethinking protocols could have a positive impact on areas of research going forward, said Bob Gold, Chief Behavioral Technologist and CEO, GoMo Health.

Although proposed expansions in telemedicine show promise, none are without drawbacks. One crucial factor is the extent to which payers would be open to covering these services.

Webcast host Burt Zweigenhaft, PhD, D.Litt, Founder, Association for Value-Based Cancer Care, acknowledged that it may be more complex in a post–COVID-19 environment. “I’m hoping that the combination of government, private enterprise, and providers will be the solution,” he said.

Related Articles
Cancer Doesn’t Quarantine: A “Thank You” to Cancer Nurses and Navigators
June 2022 Vol 13, No 6
As a little girl, Tamika Felder dreamed of being on TV. She loved watching the news even at a very young age, had an unwavering curiosity about what was going on in the world, and set her sights on a career in television, which she later achieved. What she didn’t set her sights on was a cervical cancer diagnosis at the age of 25, a radical hysterectomy, and the devastating complete loss of her fertility.
Navigation as a Catalyst to Reignite Cancer Screenings
August 2021 Vol 12, No 8
With concerted efforts by navigators, we can increase preventive screening rates.
The Need for a Complete Cancer Care Team Is Critical as We Move Out of the Pandemic
Christian Downs, JD, MHA, Linda Fleisher, PhD, MPH, Lillie D. Shockney, RN, BS, MAS, HON-ONN-CG, Mandi Pratt-Chapman, MA, PhD, HON-OPN-CG, Rani Khetarpal, MBA
|
May 2021 Vol 12, No 5
Leaders from the Academy of Oncology Nurse & Patient Navigators deliver a statement on appropriate planning to serve patients and their families in the wake of the COVID-19 pandemic.
Last modified: August 10, 2023

Subscribe Today!

To sign up for our print publication or e-newsletter, please enter your contact information below.

I'd like to receive:

  • First Name *
    Last Name *
     
     
    Profession or Role
    Primary Specialty or Disease State
    Country